FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

765959007: Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3675107010 Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3675109013 Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule est un(e) (attribut) Bendroflumethiazide and propranolol only product in oral dose form true Inferred relationship Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Plays role Diuretic therapeutic role true Inferred relationship Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has basis of strength substance (attribute) Bendroflumethiazide (substance) true Inferred relationship Some 1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has basis of strength substance (attribute) Propranolol hydrochloride true Inferred relationship Some 2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has precise active ingredient Propranolol hydrochloride true Inferred relationship Some 2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has precise active ingredient Bendroflumethiazide (substance) true Inferred relationship Some 1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule a une forme pharmaceutique (attribut) Prolonged-release oral capsule true Inferred relationship Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule est un(e) (attribut) Propranolol-containing product in oral dose form false Inferred relationship Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule est un(e) (attribut) Product containing bendroflumethiazide and propranolol (medicinal product) false Inferred relationship Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has precise active ingredient Bendroflumethiazide (substance) false Inferred relationship Some 2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Some 2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has precise active ingredient Propranolol hydrochloride false Inferred relationship Some 1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has presentation strength numerator value (attribute) 160 (qualifier value) false Inferred relationship Some 1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has presentation strength denominator value un false Inferred relationship Some 1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has basis of strength substance (attribute) Bendroflumethiazide (substance) false Inferred relationship Some 2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Some 1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has presentation strength denominator value un false Inferred relationship Some 2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has presentation strength numerator value (attribute) cinq false Inferred relationship Some 2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has basis of strength substance (attribute) Propranolol hydrochloride false Inferred relationship Some 1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has unit of presentation Capsule (unit of presentation) true Inferred relationship Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule est un(e) (attribut) Bendroflumethiazide-containing product in oral dose form false Inferred relationship Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Count of base of active ingredient deux false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start